Second malignant neoplasms following hematopoietic stem cell transplantation
Second malignant neoplasms following hematopoietic stem cell transplantation
复制标题
DOI：
10.1532/ijh97.03178
复制
发表时间：
2004-04-01
影响因子：
2.1
通讯作者：
Deeg, HJ
中科院分区：
文献类型：
--
作者：
Friedman, DL;Leisenring, W;Deeg, HJ
造血干细胞移植已成功地用于治疗各种恶性和非恶性疾病。这种疗法导致越来越多的幸存者面临不良长期结局的风险，包括发生第二次和随后的恶性肿瘤。我们回顾了移植后恶性肿瘤的发病率和谱，并讨论了危险因素和未来的研究方向。(C)2004年日本血液学会。
Hematopoietic stem cell transplantation is being successfully used to treat a variety of malignant and nonmalignant disorders. This therapy has resulted in an increasing number of survivors who are at risk for adverse long-term outcomes, including the development of second and subsequent malignant neoplasms. We review the incidence and spectrum of posttransplantation malignancies and discuss risk factors and future directions for research. (C) 2004 The Japanese Society of Hematology.